NCT06692452 2026-04-01Tazemetostat Plus CHOP in 1L T-cell LymphomaDana-Farber Cancer InstitutePhase 2 Withdrawn
NCT03586999 2024-10-29Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell LymphomasUniversity of Colorado, DenverPhase 1/2 Completed18 enrolled 14 charts
NCT00562068 2013-08-26Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell LymphomaNational Cancer Institute (NCI)Phase 1 Unknown30 enrolled